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Background: Left ventricular mass (LVM) is used when expressing infarct or fibrosis as a percentage of the left
ventricle (LV). Quantification of LVM is interchangeably carried out in cine steady state free precession (SSFP) and
delayed enhancement (DE) magnetic resonance imaging (MRI). However, these techniques may yield different LVM.
Therefore, the aim of the study was to compare LVM determined by SSFP and DE MRI in patients and determine
the agreement with these sequences with ex vivo data in an experimental animal model.
Methods: Ethics committees approved human and animal studies. Informed written consent was obtained from all
patients. SSFP and DE images were acquired in 60 patients (20 with infarction, 20 without infarction and 20
pediatric patients). Ex vivo MRI was used as reference method for LVM in 19 pigs and compared to in vivo SSFP
and DE.
Results: LVM was greater in SSFP than in DE (p < 0.001) with a bias of 5.0 ± 6.7% in humans (r
2 = 0.98), and a bias
of 7.3 ± 6.7% (p < 0.001) in pigs (r
2 = 0.83). Bias for SSFP and DE images compared to ex vivo LVM was -0.2 ± 9.0%
and -7.7 ± 8.5% respectively.
Conclusions: LVM was higher when measured with SSFP compared to DE. Thus, the percentage infarction of the
LV will differ if SSFP or DE is used to determine LVM. There was no significant difference between SSFP and ex
vivo LVM suggesting that SSFP is more accurate for LVM quantification. To avoid intrinsic error due to the
differences between the sequences, we suggest using DE when expressing infarct as a percentage of LVM.
Background
Myocardial infarct size influences patient prognosis [1]
and left ventricular (LV) remodeling [2]. Therefore,
quantification of infarct size as a percentage of the LV
myocardium is of great interest in preclinical and clini-
cal trials as well as in the clinical setting [3,4]. Magnetic
resonance imaging (MRI) has been established as the in
vivo reference method for quantification of left ventricu-
lar mass (LVM) and myocardial infarction [5-10]. Myo-
cardial infarction is quantified in delayed enhancement
(DE) MRI where infarcted myocardium is
hyperenhanced [11]. Furthermore, DE-MRI has recently
been shown to have the capability to detect fibrosis of
t h er i g h tv e n t r i c l ei np a t i e n t s with surgically corrected
congenital heart disease [12-14]. The percentage
infarcted or fibrotic myocardium of the LV is most
often calculated as the hyperenhanced myocardium in
the DE images divided by LVM in the steady state free
precession (SSFP) cine images [15-17]. However, investi-
gators have also calculated the percentage of hyperen-
hanced myocardium with LVM obtained from DE
images [18,19]. Since the assessment of LV dimensions
and LVM differ between SSFP and gradient-echo (GRE)
images [20] the LVM quantification may also differ
between DE and SSFP and this will impact the amount
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showed good agreement between DE and SSFP in deter-
mining LVM [21] but is not clear if these results are
reproducible using a MR scanner from a different ven-
dor and another patient population. Furthermore, in a
clinical study there is no reference method to determine
which sequence gives the correct LVM. High resolution
ex vivo MRI in animal models however, gives the ability
to measure LVM with high resolution and accuracy
[6,22,23] and can be used as a reference method for
LVM. Therefore, the aim of the present study was 1) to
investigate if LVM determined by SSFP images or DE
images differ in human subjects and 2) to use ex vivo
cardiac MR images in a porcine infarct model as a refer-
ence method to determine which in vivo sequence gives
the most accurate LVM.
Methods
Study population
The local ethics committee approved the study and
written informed consent was obtained from all patients
prior to examination. The animal studies were approved
by the local animal ethics committee and the study con-
formed to the Guide for the Care and Use of Laboratory
Animals, US National Institute of Health (NIH Publica-
tion No 85-23, revised 1996). Sixty patients were
included in the study; twenty adults with no signs of
myocardial infarct on DE-MRI, 20 adults with myocar-
dial infarct on DE-MRI and 20 children; five of whom
underwent cardiac MRI because of suspected myocardi-
tis but had normal findings, and 15 children who had
undergone heart surgery for tetralogy of Fallot, but had
no signs of fibrosis of the LV. Patient details are pre-
sented in Table 1. All subjects underwent cardiac MRI
in the supine position and images were acquired during
end-expiratory breath hold.
For comparison of in vivo and ex vivo LVM, nine-
teen domestic male and female pigs, weighing 40-50
kg, were imaged. After overnight fasting with free
access to water the animals were premedicated with
ketamine 15 mg/kg (Ketaminol, Intervet, Danderyd,
Sweden) and xylazin 2 mg/kg intramuscularly (Rom-
pun, Bayer AG, Leverkusen, Germany). Anesthesia was
induced with thiopental 12.5 mg/kg (Pentothal, Abbot,
Stockholm, Sweden) and infusion of fentanyl (Fentanyl,
Pharmalink AB, Stockholm, Sweden) was started.
Cardiac MRI was performed in vivo after experimen-
tally induced myocardial infarction by inflation of
angioplasty balloon in the left anterior descending cor-
onary artery distal to the first diagonal branch. After
the animals were sacrificed, their hearts were explanted
and imaged ex vivo according to a previously described
protocol [24,25]. See below for details.
MR imaging
A 1.5 Tesla MRI scanner with a 5-element cardiac
synergy coil was used for all in vivo and ex vivo studies
(Philips Intera CV, Philips, Best, the Netherlands). SSFP
and DE images were acquired covering the left ventricle
from the base to the apex in the short-axis plane. Inver-
sion time was set to null viable myocardium. Typical
MRI sequence parameters for SSFP were: echo time 1.5
ms, repetition time 3 ms, flip angle 60°, slice gap 0 mm,
slice thickness 8 mm (6 mm in children), inplane resolu-
tion 1.1 × 1.1 to 1.6 × 1.6 mm and SENSE factor 2.
An inversion recovery GRE-sequence was used to
obtain DE images in the short axis plane 10-20 minutes
after intravenous administration of 0.2 mmol/kg gadoli-
nium based MR contrast media (Magnevist, Bayer
Pharma, Berlin, Germany). Acquisition time for DE was
mid diastole. For DE the sequence parameters were:
echo time 1.3 ms, repetition time 4 ms, flip angle 15°,
slice gap 0 mm and slice thickness 8 mm, inplane reso-
lution 0.9 × 0.9 to 1.6 × 1.6 mm.
In vivo imaging of the animals was performed using
the same SSFP and DE imaging parameters as in
patients. Following euthanasia the animal hearts were
removed, the atria excised and the ventricles filled with
deuterated water. Ex vivo T1-weighted (T1w) MR ima-
ging was performed with a quadrature head coil cover-
ing the left ventricle from the base to the apex, typically
resulting in 150 image slices per heart. The sequence
parameters were: echo time 3.2 ms, repetition time 20
ms, flip angle 70°, slice gap 0 mm and slice thickness
0.5 mm, inplane resolution 0.5 × 0.5.
All MR images were evaluated by two blinded obser-
vers using freely available software (Segment 1.688,
http://segment.heiberg.se). The LVM was quantified by
outlining the endo- and epicardium of the left ventricle
in the SSFP, DE and ex vivo images and multiplying the
resulting volume by 1.05. Outlining of in vivo images
was carried out in end diastole and end systole and the
mean value calculated. The papillary muscles were
Table 1 Patient characteristics
Children Patients without MI Patients with MI
N 20 20 20
Age in years (range) 12 ± 3 (9-17) 59 ± 8 (42-76) 70 ± 11 (42-82)
Females/Males 11/9 9/11 6/14
MI, myocardial infarction
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in reference values for LVM [26].
Statistical analysis
Continuous variables were presented as mean ± SD and
range. Pearson’sc o r r e l a t i o nw a su s e dt od e t e r m i n et h e
relationship between different techniques in determining
LVM. Two-tailed paired t-test was used to detect differ-
ences in LVM between the two techniques. A p-value
below 0.05 was considered significant. Bias between
LVM using SSFP and DE was calculated according to
Bland-Altman and presented as the mean difference ±
SD. Bias between ex vivo LVM and SSFP or DE was cal-
culated using ex vivo as reference LVM. Interobserver
variability was calculated for all subjects and presented
as mean ± SD.
Results
Representative short axis MR images of the LV in
patients and pigs are illustrated in Figure 1. MR images
with corresponding delineations of the LVM from the
three sequences used in the study, namely SSFP, DE and
ex vivo T1w are shown. LVM assessment on DE and
SSFP in the three patient groups as well as the in-vivo
animals is presented in table 2.
Patients
Myocardial mass measured with SSFP images (126.2 ±
52.1 g, range 37.3-285.4 g) was higher compared to DE
images (120.5 ± 50.6 g, range 37.4-275.1 g, p < 0.001).
The bias for LVM measurement between SSFP and DE
images was 5.0 ± 6.7% (figure 2). However, the correla-
tion between LVM determined on SSFP and DE images
was high (r
2 = 0.98, p < 0.001, LVMSSFP = 1.0
(LVMDE)+3.5). The difference in LVM between SSFP
and DE remained if the 20 patients with myocardial
infarct (MI) were excluded (109.6 ± 46.7 g vs. 103.1 ±
44.2 g respectively, p < 0.001, r
2 = 0.98, p < 0.001,
LVMSSFP = 1.0(LVMDE)+1.7). LVM in the 40 subjects
without MI was higher by 6.2 ± 6.9% (p < 0.001) when
measured with SSFP compared to DE. In the 20 patients
with MI the bias was 2.5 ± 5.5% (p < 0.001).
Animals
LVM in pigs was also higher when measured with SSFP
(100.9 ± 15.9 g, range 80.9-133.6 g) compared to DE
(93.6 ± 14.5 g, range 71.4-127.2 g, p < 0.001). The bias
for LVM measurement between SSFP and DE images
was 7.5 ± 6.9%. There was a moderate correlation (r
2 =
0.69, p < 0.001, LVMSSFP = 1.3(LVMex-vivo)+30.1)
between LVM measured on SSFP and ex vivo T1w MRI
(100.4 ± 10.1 g, range 84.4-119.5 g) and the difference
between the methods was not significant (0.2 ± 9.0%, p
= 0.82), (figure 3). In contrast, LVM was higher on ex
vivo MRI compared to DE (7.7 ± 8.5%, p < 0.01)
although the correlation was similar (r
2 = 0.72, p < 0.01,
LVMDE = 1.2(LVMex-vivo)-28.6), (figure 4). Interobser-
ver variability for the measurements of LVM in humans
and pigs was 2.9 ± 6.6% for SSFP and 2.7 ± 6.7% for DE.
Discussion
This study has shown that SSFP MRI yields significantly
higher LVM compared to DE MRI in patients. This dif-
ference was also confirmed in animals where LVM
determined in vivo on SSFP most closely resembled
LVM measured on high resolution ex vivo MRI. Quanti-
fication of infarct size as percentage of LVM on MRI
will be influenced by this difference in LVM between
the SSFP and DE sequences.
Quantification of infarct size is an important prognos-
tic factor in patients with ischemic heart disease [1,2].
The extent of fibrotic myocardium is also of value in
patients who have had surgery for congenital heart dis-
ease, such as tetralogy of Fallot [14] as it affects right
ventricular function in adulthood and is related to
restrictive physiology, exercise intolerance and arrhyth-
mias [27]. In this study we have evaluated two methods
used to quantify LVM when calculating infarct as per-
centage of LVM and showed that they are not inter-
changeable. The LVM was higher when measured with
SSFP cine sequences compared to DE sequences. There-
fore the proportion of infarct of the LVM will differ
depending if SSFP images or DE images are used to
determine LVM. The findings of the current study are
in contrast with previous findings by Grothues et al who
found good correlation between the two techniques but,
opposite to our results, generally lower values of myo-
cardial mass when measured with SSFP [21]. Possible
reasons for this discrepancym a yb ed u et od i f f e r e n c e s
in 1) MRI scanners, 2) patient populations and 3) deli-
neation technique. Grothues et al studied patients with
a first time documented myocardial infarct but we also
included patients with no infarction and children. In the
Table 2 LVM measurements on DE and SSFP in the three study groups and the pigs
Children Patients without MI Patients with MI Total Pigs
LVM on DE in grams
(range)
73.7 ± 31.8 (37.4-
151.6)
132.4 ± 32.8 (93.5-
220.2)
155.4 ± 44.0 (74.6-
275.1)
120.5 ± 50.6 (37.4-
275.1)
93.6 ± 14.5 (71.4-
127.2)
LVM on SSFP in grams
(range)
79.4 ± 34.0 (37.3-
162.7)
139.7 ± 35.7 (97.6-
242.8)
159.5 ± 45.8 (77.1-
285.4)
126.2 ± 52.1 (37.3-
285.4)
100.9 ± 15.9 (80.9-
133.6)
Bias 7.2 ± 8.4% 5.2 ± 5.0% 2.5 ± 5.5% 5.0 ± 6.7% 7.5 ± 6.9%
LVM, left ventricular mass; DE, delayed enhancement; SSFP, steady state free precession; MI, myocardial infarct
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in patients with MI compared to those without MI, sug-
gesting that parts of the discrepancy between the two
studies can be explained by the different patient popula-
tions. Furthermore, our results were confirmed in an
experimental setting with high resolution ex vivo
imaging.
In the clinical setting the difference of 5.0% ± 6.7%
may be considered negligible and this is supported by
the high correlation between the methods. However, it
is important to be aware of this discordance and use the
same acquisition method in the follow-up of patients,
for example when following infarct shrinkage [28-30].
Due to the differences between sequences there is a risk
of introducing intrinsic error, when calculating infarct
size using variables from two different sequences.
Indeed, in the study of Grotheus et al, LVM measured
on a GE scanner revealed higher LVM on DE than SSFP
Figure 1 Short axis images of the heart on SSFP (top row) and DE (middle row) sequences in a child (left column), an adult (middle
column) and a pig (right column). Bottom row shows the ex vivo T1w image of the pig heart.
Figure 2 Pearson’s correlation and Bland-Altman analysis of LVM measured on SSFP and DE in all 60 patients. Open circles signify the
40 patients without infarcts and crosses signify the 20 patients with infarcts.
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become even greater when comparing results from dif-
ferent types of MRI scanners and using different
sequences. Therefore, we suggest using DE for the
quantification of LVM and the infarcted area when pre-
senting percentage infarct quantification. When using
automated quantification of infarct size, which is recom-
mended for scientific purposes [10], delineation of the
myocardium in DE images is necessary. Therefore, this
does not add extra delineations of the myocardium.
However, the high accuracy and precision of the SSFP
sequence, compared to ex vivo imaging, supports the
use of SSFP sequences when determining LVM in the
clinical setting. In any case, the methodology for LVM
measurements must be determined and should be stated
when performing clinical or preclinical studies. The pre-
sence of infarction may influence the quantification of
LVM on DE, since the delineation of the endocardial
border can be difficult. However this did not seem to
affect the results of the present study, as the LVM was
smaller in DE compared to SSFP both in hearts with
and without MI. In pigs we considered the ex vivo
images as the reference standard that best estimates the
real LVM. There was no significant difference between
the SSFP images and the ex vivo images and therefore
one can assume that the SSFP images give better
assessment of LVM, while it is slightly underestimated
in the DE images. A possible explanation for this discre-
pancy is that SSFP sequences give better contrast
between papillary muscles and blood. In the DE
sequences the papillary muscles and trabeculations are
not as clear, running the risk that they are not included
in the delineation and measurement of myocardial mass.
This can also be influenced by the time of imaging after
contrast administration which can affect the myocardial
to blood contrast.
Limitations
We included a diverse group of subjects with a wide
range of age and myocardial mass. However, all patients
were examined with the same type of scanner (1.5 T
Philips Intera CV) and DE sequence and it is possible
that other vendors and sequences may yield different
results. We did not measure the weight of the LVM in
the animals but rather used ex vivo high resolution MRI
to obtain the LVM. This could have provided an inde-
pendent variable for further valuation of the results. The
myocardial-to-blood contrast-to-noise ratio was not
measured for each subject. However, when acquiring the
DE imaging great care was taken to choose the right
inversion time to null all viable myocardium. These fac-
tors may be considered when performing further studies
on this subject.
Figure 3 Pearson’s correlation and Bland Altman analysis of LVM in pigs measured on SSFP and ex vivo.
Figure 4 Pearson’s correlation and Bland Altman analysis of LVM in pigs measured on DE and ex vivo.
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The present study has shown a higher LVM on SSFP
compared to DE MRI in patients and animals and that
SSFP agrees closely with ex vivo high resolution MRI.
We suggest using SSFP when quantifying LVM only,
but using mass from DE when presenting infarction as
percentage of LVM. The difference in LVM on different
MRI sequences found in the present study needs to be
considered in future guidelines for quantification of
infarct size.
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